Related Experiment Videos
Molecular targets for breast cancer therapy and prevention
1Max-Planck-Institut of Biochemistry, Department of Molecular Biology Martinsried, Germany.
Abstract:
The recent completion of the human genome sequence has raised great hopes for the discovery of new breast cancer therapies based on newly-discovered genes linked to breast cancer development and progression. Here we describe breast cancer therapies that have emerged from gene-based scientific efforts over the past 20 years and that are now approved for clinical testing or treatment.
Insights
Gene-based research following the human genome sequence has yielded new breast cancer therapies. These advancements, developed over 20 years, are now available for clinical testing and treatment.
Area of Science:
- Genomics and Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- The completion of the human genome sequence has accelerated the identification of genes implicated in breast cancer.
- Understanding the genetic basis of breast cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To review gene-based breast cancer therapies developed over the past two decades.
- To highlight therapies approved for clinical testing or treatment.
Main Methods:
- Literature review of gene-based research in breast cancer.
- Analysis of therapies emerging from genomic studies.
- Compilation of approved clinical trials and treatments.
Main Results:
- Several novel breast cancer therapies have arisen from gene-based research.
- These therapies target specific genetic alterations involved in breast cancer.
- A significant number of these therapies have reached clinical validation.
Conclusions:
- Gene-based scientific efforts have significantly advanced breast cancer treatment options.
- The human genome sequence has been instrumental in discovering targeted therapies.
- Continued genomic research promises further breakthroughs in breast cancer care.